Pharmaceutical Executive August 2014

August 2014 | Volume 0, Issue 0
By Pharmaceutical Executive Editors
This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise—all binded by an underlying commitment to the patient.
Mid-career students on Brown University's new program are challenged to remove the organizational silos that slow innovations in the delivery and financing of healthcare.
By Pharmaceutical Executive Editors
Industry's grand vision for reshaping the life sciences in Europe may ultimately prove to be a lost cause.
By Pharmaceutical Executive Editors
Three medical affairs experts review the capabilities of Google's latest technology for delivering information to healthcare professionals in the field.
By Pharmaceutical Executive Editors
The importance of pre-acquisition due diligence.
Tweeting limited, corrections okay, says FDA, as industry, regulators wrestle with the digital world. Our Washington Correspondent Jill Wechsler reports.
From the Editor
Pharm Exec's 2014 roster of emerging pharma leaders serves as a window on work in an industry that relies on human capital as the coinage of success, writes William Looney.
Special Sponsored Section
By Pharmaceutical Executive Editors
2014 kicks off a defining period for healthcare in Chile as a new national drug law is implemented, with the hopes of creating a system that makes access to medicines easier and more transparent for patients.
lorem ipsum